- Home
- LRHC vs DWTX Comparison
LRHC vs DWTX Comparison
Compare LRHC & DWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- DWTX
- Stock Information
- Founded
- LRHC 2004
- DWTX 2012
- Country
- LRHC United States
- DWTX United States
- Employees
- LRHC N/A
- DWTX N/A
- Industry
- LRHC
- DWTX
- Sector
- LRHC
- DWTX
- Exchange
- LRHC Nasdaq
- DWTX NYSE
- Market Cap
- LRHC 6.7M
- DWTX 5.9M
- IPO Year
- LRHC 2023
- DWTX N/A
- Fundamental
- Price
- LRHC $0.15
- DWTX $5.66
- Analyst Decision
- LRHC
- DWTX Strong Buy
- Analyst Count
- LRHC 0
- DWTX 1
- Target Price
- LRHC N/A
- DWTX $10.00
- AVG Volume (30 Days)
- LRHC 20.2M
- DWTX 2.4M
- Earning Date
- LRHC 04-15-2025
- DWTX 05-14-2025
- Dividend Yield
- LRHC N/A
- DWTX N/A
- EPS Growth
- LRHC N/A
- DWTX N/A
- EPS
- LRHC N/A
- DWTX N/A
- Revenue
- LRHC $69,448,786.00
- DWTX N/A
- Revenue This Year
- LRHC N/A
- DWTX N/A
- Revenue Next Year
- LRHC N/A
- DWTX N/A
- P/E Ratio
- LRHC N/A
- DWTX N/A
- Revenue Growth
- LRHC 118.67
- DWTX N/A
- 52 Week Low
- LRHC $0.09
- DWTX $1.62
- 52 Week High
- LRHC $3.36
- DWTX $29.28
- Technical
- Relative Strength Index (RSI)
- LRHC 42.67
- DWTX N/A
- Support Level
- LRHC $0.09
- DWTX N/A
- Resistance Level
- LRHC $0.22
- DWTX N/A
- Average True Range (ATR)
- LRHC 0.03
- DWTX 0.00
- MACD
- LRHC -0.00
- DWTX 0.00
- Stochastic Oscillator
- LRHC 46.29
- DWTX 0.00
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has five reportable segments namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management and Real Estate Brokerage Services (Commercial). It derives maximum revenue from Real Estate Brokerage Services (Residential) segment.
About DWTX DOGWOOD THERAPEUTICS INC
Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.